Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 18;11(4):1072.
doi: 10.3390/jcm11041072.

A Novel Doppler TRPG/AcT Index Improves Echocardiographic Diagnosis of Pulmonary Hypertension after Pulmonary Embolism

Affiliations

A Novel Doppler TRPG/AcT Index Improves Echocardiographic Diagnosis of Pulmonary Hypertension after Pulmonary Embolism

Olga Dzikowska-Diduch et al. J Clin Med. .

Abstract

Background: We hypothesized that a Doppler index, the ratio of tricuspid regurgitation peak gradient (TRPG) to pulmonary ejection acceleration time (AcT), improves the assessment of the echocardiographic probability of pulmonary hypertension in the identification of CTEPH and chronic thromboembolic pulmonary disease (CTED) in symptomatic patients after PE. Doppler echocardiography is recommended as the initial imaging tool for the diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH) after acute pulmonary embolism (PE).

Methods: We analyzed the data from 845 consecutive PE (468 women; 61 ± 18 years) survivors who completed at least 6 months of anticoagulation therapy. Here, 555 patients (325 women; 66 ± 16 years) reporting functional impairment (FI) underwent transthoracic echocardiography. We included 506 patients (297 women; age 63.4 ± 16.6 years) in whom both AcT and TRPG were available into the current study. The presence of a minimum of intermediate echocardiographic probability of PH necessitated the diagnosis of CTEPH.

Results: Echocardiography revealed a high echocardiographic probability of PH in 69 (13.6%) and intermediate echocardiographic probability in 109 (21.5%) patients. CTEPH was diagnosed in 35 (6.9%) patients and CTED in 22 (4.3%) patients. TRPG/AcT was significantly higher in the combined CTEPH + CTED group than in those with other causes of FI (0.412 (0.100-2.197) vs. 0.208 (0.026-0.115), p < 0.001), and the area under the receiver operating characteristic curve of the TRPG/AcT for CTEPH + CTED was 0.804 (95% confidence interval (CI): 0.731-0.876). Importantly, multiple logistic regression showed that TRPG/AcT is a significant predictor of CTEPH + CTED after considering echocardiographic probability (odds ratio = 1.51, 95% CI: 1.25-1.91, p < 0.001). Conditional inference trees analysis revealed that TRPG/AcT > 0.595 identified patients with CTEPH or CTED with a positive predictive value of 78.6% and negative predictive value of 92.7%.

Conclusions: A Doppler index TRPG/AcT improves the assessment of symptomatic PE survivors. TRPG/AcT > 0.6 indicates a high probability of CTEPH or CTED, whereas TRPG/AcT < 0.6 allows for the safe exclusion of CTEPH + CTED in patients with a low echocardiographic probability of PH.

Keywords: chronic thromboembolic pulmonary hypertension; echocardiographic probability of pulmonary hypertension; echocardiography; pulmonary embolism.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Follow up study of PE survivors. PE—pulmonary embolism, PH—pulmonary hypertension, CTEPH—chronic thromboembolism pulmonary hypertension, CTED—chronic thrombo-embolic disease, EF—ejection fraction, LV—left ventricular, COPD—chronic obstructive pulmonary disease, CAD—coronary artery disease, VHD—valvular heart disease.
Figure 2
Figure 2
Distribution of TRPG/AcT parameter across groups. CTEPH—chronic thromboembolic pulmonary hypertension; CTED—chronic thromboembolic disease, TRPG/AcT tricuspid regurgitation peak gradient/pulmonary ejection acceleration time.
Figure 3
Figure 3
ROC Curves for the TRPG/AcT for the diagnosis of CTEPH (A) and for the diagnosis of pooled CTEPH and CTED groups (B). AUC—area under the roc curve; CTEPH—chronic thromboembolic pulmonary hypertension; CTED—chronic thromboembolic disease; ROC—receiver operating characteristic; TRPG/AcT tricuspid regurgitation peak gradient/pulmonary ejection acceleration time.
Figure 4
Figure 4
Echocardiographic diagnostic algorithm of CTEPH and CTED in pulmonary embolism survivors with functional impairment: (A) for CTEPH, (B) for combined CTEPH with CTED. AcT—pulmonary ejection acceleration time, CTED—chronic thromboembolic disease, CTEPH—chronic thromboembolic pulmonary hypertension, ESC—European Society of Cardiology, TRPG—tricuspid regurgitation peak gradient, PH—pulmonary hypertension.
Figure 4
Figure 4
Echocardiographic diagnostic algorithm of CTEPH and CTED in pulmonary embolism survivors with functional impairment: (A) for CTEPH, (B) for combined CTEPH with CTED. AcT—pulmonary ejection acceleration time, CTED—chronic thromboembolic disease, CTEPH—chronic thromboembolic pulmonary hypertension, ESC—European Society of Cardiology, TRPG—tricuspid regurgitation peak gradient, PH—pulmonary hypertension.

References

    1. Klok F.A., van der Hulle T., den Exter P.L., Lankeit M., Huisman M.V., Konstantinides S. The post-PE syndrome: A new concept for chronic complications of pulmonary embolism. Blood Rev. 2014;28:221–226. doi: 10.1016/j.blre.2014.07.003. - DOI - PubMed
    1. Klok F.A., Barco S. Follow-up after acute Pulmonary Embolism. Hamostaseologie. 2018;38:22–32. - PubMed
    1. Dzikowska-Diduch O., Kostrubiec M., Kurnicka K., Lichodziejewska B., Pacho S., Miroszewska A., Bródka K., Skowrońska M., Łabyk A., Roik M., et al. The post-pulmonary syndrome—Results of echocardiographic driven follow up after acute pulmonary embolism. Thromb. Res. 2020;186:30–35. doi: 10.1016/j.thromres.2019.12.008. - DOI - PubMed
    1. Kahn S.R., Comerota A.J., Cushman M., Evans N.S., Ginsberg J.S., Goldenberg N.A., Gupta D.K., Prandoni P., Vedantham S., Walsh M.E., et al. The postthrombotic syndrome: Evidence-based prevention, diagnosis, and treatment strategies: A scientific statement from the American Heart Association. Circulation. 2014;130:1636–1661. doi: 10.1161/CIR.0000000000000130. - DOI - PubMed
    1. Ende-Verhaar Y.M., Cannegieter S.C., Vonk Noordegraaf A., Delcroix M., Pruszczyk P., Mairuhu A.T., Huisman M.V., Klok F.A. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: A contemporary view of the published literature. Eur. Respir. J. 2017;49:1601792. doi: 10.1183/13993003.01792-2016. - DOI - PubMed

LinkOut - more resources